Anbio Biotechnology Research and Development Expense
Anbio Biotechnology (NNNN) reported Research and Development Expense of $201.31 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-07
| Period end | Research and Development Expense 12 month |
|---|---|
| 2025-12-31 | $201.31K 20-F · filed 2026-04-07 |
| 2024-12-31 | $454.23K 20-F · filed 2026-04-07 |
| 2023-12-31 | $134.70K 20-F · filed 2026-04-07 |
| 2022-12-31 | $200.00K 20-F · filed 2025-04-28 |